Yes, fibrin and its degradation products can serve as potential biomarkers for exposure to certain toxins. The presence of abnormal levels of fibrin or its breakdown products in the blood can indicate disruptions in the coagulation system, which may be linked to toxic exposure. These biomarkers can assist in the early detection and management of toxin-induced health effects.
